Comments
Loading...
Stime degli utili, EPS e fatturato
Tandem Diabetes Care segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 6
Stima EPS
$-0.330
Stima dei ricavi trimestrali
$236.56M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$1.00B
Analizza lo storico degli utili di Tandem Diabetes Care utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
TNDM | Tandem Diabetes Care | -$0.36 | -$0.33 | — | — | $243.97M | $236.56M | — | — | 11/06/2025 | |
TNDM | Tandem Diabetes Care | -$0.47 | -$0.40 | -$0.78 | -95.00% | $221.91M | $238.48M | $240.68M | 0.92% | 08/06/2025 | |
TNDM | Tandem Diabetes Care | -$0.64 | -$0.61 | -$0.67 | -9.02% | $191.67M | $220.22M | $234.42M | 6.45% | 04/30/2025 | |
TNDM | Tandem Diabetes Care | -$0.27 | -$0.24 | -$0.44 | -83.33% | $196.80M | $251.39M | $282.65M | 12.43% | 02/26/2025 | |
TNDM | Tandem Diabetes Care | -$0.38 | -$0.40 | -$0.36 | 10.00% | $185.62M | $223.66M | $243.97M | 9.08% | 11/06/2024 | |
TNDM | Tandem Diabetes Care | -$0.30 | -$0.54 | -$0.48 | 11.11% | $195.92M | $205.63M | $221.91M | 7.92% | 08/01/2024 | |
TNDM | Tandem Diabetes Care | -$0.63 | -$0.76 | -$0.64 | 15.79% | $169.38M | $173.92M | $191.67M | 10.21% | 05/02/2024 | |
TNDM | Tandem Diabetes Care | -$0.01 | -$0.25 | -$0.27 | -8.00% | $220.50M | $203.41M | $196.80M | -3.25% | 02/21/2024 | |
TNDM | Tandem Diabetes Care | -$0.27 | -$0.34 | -$0.38 | -11.76% | $204.55M | $192.34M | $185.62M | -3.49% | 11/01/2023 | |
TNDM | Tandem Diabetes Care | -$0.24 | -$0.53 | -$0.30 | 43.40% | $200.26M | $197.64M | $195.92M | -0.87% | 08/03/2023 | |
TNDM | Tandem Diabetes Care | -$0.23 | -$0.52 | -$0.63 | -21.15% | $175.91M | $170.23M | $169.38M | -0.50% | 05/03/2023 | |
TNDM | Tandem Diabetes Care | $0.16 | -$0.06 | -$0.01 | 83.33% | $210.00M | $221.83M | $220.50M | -0.60% | 02/22/2023 | |
TNDM | Tandem Diabetes Care | $0.09 | -$0.05 | -$0.27 | -440.00% | $179.63M | $208.16M | $204.55M | -1.74% | 11/02/2022 | |
TNDM | Tandem Diabetes Care | $0.06 | $0.02 | -$0.24 | -1300.00% | $172.14M | $205.20M | $200.26M | -2.41% | 08/03/2022 | |
TNDM | Tandem Diabetes Care | -$0.08 | -$0.07 | -$0.23 | -228.57% | $141.04M | $168.43M | $175.91M | 4.44% | 05/04/2022 | |
TNDM | Tandem Diabetes Care | $0.22 | $0.21 | $0.16 | -23.81% | $168.06M | $199.12M | $210.00M | 5.46% | 02/22/2022 | |
TNDM | Tandem Diabetes Care | -$0.15 | $0.06 | $0.09 | 50.00% | $123.60M | $171.41M | $179.63M | 4.79% | 11/03/2021 | |
TNDM | Tandem Diabetes Care | -$0.45 | -$0.08 | $0.06 | 175.00% | $109.24M | $143.63M | $172.14M | 19.85% | 08/04/2021 | |
TNDM | Tandem Diabetes Care | -$0.25 | -$0.16 | -$0.08 | 50.00% | $97.93M | $121.96M | $141.04M | 15.64% | 05/05/2021 | |
TNDM | Tandem Diabetes Care | $0.04 | $0.12 | $0.22 | 83.33% | $108.40M | $141.58M | $168.06M | 18.71% | 02/24/2021 | |
TNDM | Tandem Diabetes Care | -$0.09 | -$0.10 | -$0.15 | -50.00% | $94.66M | $115.15M | $123.60M | 7.34% | 11/05/2020 |
Tandem Diabetes Care (TNDM) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $-0.78 | $-0.40 | -95.0 % |
| Q1 | 2025-04-30 | $-0.67 | $-0.61 | -9.02 % |
| Q4 | 2025-02-26 | $-0.44 | $-0.24 | -83.3 % |
| Q3 | 2024-11-06 | $-0.36 | $-0.40 | 10.0 % |
Tandem Diabetes Care (TNDM) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $240.68M | $238.48M | 0.92 % |
| Q1 | 2025-04-30 | $234.42M | $220.22M | 6.45 % |
| Q4 | 2025-02-26 | $282.65M | $251.39M | 12.4 % |
| Q3 | 2024-11-06 | $243.97M | $223.66M | 9.08 % |
FAQ
Quando Tandem Diabetes Care (NASDAQ:TNDM) riporterà gli utili?
Si prevede che Tandem Diabetes Care (TNDM) fornisca risultati il novembre 6, 2025. Gli ultimi risultati sono stati pubblicati il agosto 6, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Tandem Diabetes Care (NASDAQ:TNDM)?
L'EPS effettivo era $-0.78, che mancato la stima di $-0.40.
Quali sono state le entrate di Tandem Diabetes Care (NASDAQ:TNDM)?
Le entrate effettive sono state $240.7M, che superato la stima di $238.5M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.